CIBC World Market
CLDX icon

CIBC World Market’s Celldex Therapeutics CLDX Stock Holding History

CIBC World Market’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,000
Closed -$520K – 1098
2020
Q2 		$520K Buy
+40,000
New +$177K ﹤0.01% 783
2015
Q4 		– Sell
-2,607
Closed -$412K – 887
2015
Q3 		$412K Buy
2,607
+2,067
+383% +$585K ﹤0.01% 655
2015
Q2 		$204K Hold
540
– – ﹤0.01% 839
2015
Q1 		$226K Sell
540
-667
-55% -$239K ﹤0.01% 739
2014
Q4 		$330K Buy
+1,207
New +$300K ﹤0.01% 680

Other funds holding CLDX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CIBC World Market's CLDX Position: Q3 2020 in Review

CIBC World Market sold out of Celldex Therapeutics (CLDX) in Q3 2020, closing a stake of 40,000 shares — an estimated $520K sold.

CIBC World Market first reported a position in CLDX in Q4 2014 and held it in 5 quarters. The position peaked at $520K in Q2 2020. 91 funds tracked by Wall St. Rank hold CLDX as of Q3 2020.

  • CIBC World Market reported no remaining Celldex Therapeutics position as of Q3 2020 after selling out during the quarter.
  • CIBC World Market sold 40,000 Celldex Therapeutics shares in Q3 2020, an estimated $520K.
  • CIBC World Market first reported a position in Celldex Therapeutics in Q4 2014 and held it in 5 quarters.
  • CIBC World Market's Celldex Therapeutics position peaked at $520K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2020.

Based on CIBC World Market's 13F filing for Q3 2020, filed 12 Nov 2020.